# Analyzing How Genetics May Affect Response to High Blood Pressure Medications

> **NCT00563901** · — · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 37939 (actual)

## Conditions studied

- Hypertension
- Coronary Disease
- Cerebrovascular Accident

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00563901
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** 2004-05
- **Final completion:** 2004-05
- **Target enrollment:** 37939 (ACTUAL)
- **Last updated:** 2014-03-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00563901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00563901, "Analyzing How Genetics May Affect Response to High Blood Pressure Medications". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00563901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*